<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Westenend, P.</title>
    <link>http://repub.eur.nl/res/aut/15382/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Variation between hospitals in surgical margins after first breast-conserving surgery in the Netherlands (Article)</title>
      <link>http://repub.eur.nl/res/pub/35037/</link>
      <pubDate>2012-01-01T00:00:00Z</pubDate>
      <description>Surgical margin status after first breast-conserving surgery (BCS) is used as a quality indicator of breast cancer care in the Netherlands. The aim is to describe the variation in surgical margin status between hospitals. 7,345 patients with DCIS or invasive cancer (T1-2,N0-1,M0) diagnosed between July 1, 2008, and June 30, 2009, who underwent BCS as first surgery, were selected from the Netherlands Cancer Registry. Patients were treated in 96 hospitals. Maximum target values were 30% 'focally positive' or 'more than focally positive' for DCIS and 10% 'more than focally positive' for invasive carcinoma. Results per hospital are presented in funnel plots. For invasive carcinoma, multivariate logistic regression was used to adjust for case mix. Overall 28.5% (95% CI: 25.5-31.4%) of DCIS and 9.1% (95% CI: 8.4-9.8%) of invasive carcinoma had positive margins. Variation between hospitals was substantial. 6 and 10 hospitals, respectively, for DCIS and invasive cancer showed percentages above the upper limit of agreement. Case mix correction led to significant different conclusions for 5 hospitals. After case mix correction, 10 hospitals showed significant higher rates, while 7 hospitals showed significant lower rates. High rates were not related to breast cancer patient volume or type of hospital (teaching vs. non-teaching). Higher rates were related to hospitals where the policy is to aim for BCS instead of mastectomy. The overall percentage of positive margins in the Netherlands is within the predefined targets. The variation between hospitals is substantial but can be largely explained by coincidence. Case mix correction leads to relevant shifts. </description>
    </item> <item>
      <title>Idiopathic retroperitoneal fibrosis mimicking malignant lymphoma (Article)</title>
      <link>http://repub.eur.nl/res/pub/34287/</link>
      <pubDate>2011-10-06T00:00:00Z</pubDate>
      <description>We present a case of atypical idiopathic retroperitoneal fibrosis (iRPF) presenting as a large pelvic tumor, for which it proved difficult to exclude T-cell malignant lymphoma. Histopathological examination of biopsy material showed collagenous tissue and fat with an exuberant and predominant T-cell infiltrate, largely consisting of CD4+cells expressing the IL-2 receptor-α chain (CD25). Focal plasma cells were negative for the immunoglobulin G4 (IgG4) isotype. T-cell receptor gene rearrangement (TRGR) pattern showed a Gaussian distribution, in keeping with a polyclonal T-cell population. Awareness of the sometimes exuberant and predominant T-cell infiltrate in iRPF should lead to earlier consideration of this disorder. This is particularly the case where there is an atypically localized and/or extensive mass, for which early exclusion of monoclonality with TRGR may provide helpful. Immunohistochemical findings suggest that CD4+CD25+cells, which are part of a naturally occurring population of regulatory T-cells, may be involved in the pathogenesis of iRPF. © 2011 The Authors. Pathology International </description>
    </item> <item>
      <title>Mycobacterium heckeshornense infection in an immunocompetent patient and identification by 16S rRNA sequence analysis of culture material and a histopathology tissue specimen. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13500/</link>
      <pubDate>2004-09-01T00:00:00Z</pubDate>
      <description>Mycobacterium heckeshornense is a rare isolate in clinical specimens. We
      performed simultaneous 16S rRNA sequence analysis of a mycobacterium
      culture and a histopathology specimen to determine the relevance of M.
      heckeshornense infection in an immunocompetent patient initially
      presenting with pneumothorax.</description>
    </item>
  </channel>
</rss>